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NH,-terminal amino acid sequence of the pS2 protein produced and secreted by human gastric cancer cells, MKN-45, was determined to be identical 
to that of MCF-7 cells. A clone encoding pS2 protein was isolated from the cDNA library constructed from MKN-45 cells. The nucleotide sequence 
was identical to that of pS2 cDNA previously isolated from human breast cancer cells, MCF-7, except for one nucleotide in the 3’ untranslated 
region. Thus, in this cell line, the pS2 gene product is translated and secreted as in MCF-7 cells. RNA blot hybridization analysis revealed that 
pS2 gene was expressed well in two (MKN-45 and KATO-III; derived from poorly differentiated adenocarcinoma) but not in three cell lines (MKN- 
1, MKN-28 and MKN-74; from well differentiated adenocarcinoma), suggesting that expression of the pS2 gene depends on the state of cell differen- 
tiation. These results suggest hat pS2 is expressed in human gastric cancer cells in an ~~ogen-ind~ndent manner and is possibly associated 
with the malignant state of cells. 
pS2; Human gastric cancer cell; Transcription; Processing 
1. INTRODUCTION 
The pS2 gene is originally isolated from human 
breast cancer cells, MCF-7, with its inducibility by 
estrogen [l]. This gene encodes a protein composed of 
84 amino acids [2]. The protein is purified from the 
serum-free medium conditioned by MCF-7 cells and the 
amino acid sequence of this purified protein shows that 
it is secreted into the medium as a polypeptide of 60 
amino acids after the signal polypeptide cleavage [3]. 
Activation of transcription of the pS2 gene is a primary 
response to estrogen in MCF-7 cells [4]. The pS2 pro- 
tein was first deduced to be an autocrine growth factor 
for this cell line because expression and cell prolifera- 
tion were likely to occur simultaneously. But ex- 
periments with MCF-7 variant cells [5] and time course 
experiments [6] suggest hat this polypeptide is not an 
autocrine growth regulator. At present, the biological 
significance of this pol~eptide remains to be un- 
covered. 
In our current study, the expression of pS2 gene was 
investigated in gastric cancer cell lines derived from 
well or poorly differentiated and hormone-independent 
adenocarcinoma, at transcriptional and secreted levels 
in the conditioned medium. 
2. MA~RIALS AND METHODS 
2.1. Cell culture procedure 
Five human gastric cancer cell lines obtained from Im- 
munobiological Laboratory (Japan) were cultured as described for 
MCF-7 cells but without insulin nor Bestradio [a]. For preparation 
of RNA, cells were scraped from the dishes and stored at -80°C. 
Cells for purification of pS2 protein were cultured as described 
previously [3]. 
2.2. Assay of pS2 protein 
Assay of pS2 samples was performed with the two site enzyme im- 
munoassay as described previously 161. 
2.3. purification of pS.2 protein and amino acid sequence anat~s~ 
Purification of pS2 protein and its sequence analysis were carried 
out as described previously [3]. 
pS2 is expressed well in estrogen receptor-positive 
breast cancers but not in normal breast cells [7]. Thus, 
in breast, the expression of pS2 is highly estrogen- 
dependent. However, pS2 is expressed well in stomach 
mucosa [8], suggesting the expression of this gene is not 
necessarily hormone-dependent in other celI types. 
2.4. cDNA library construction 
Total RNA was extracted from MKN-45 celk and poly(A)+ RNA 
was prepared as described previously [lo]. The MKN-45 cell cDNA 
library was constructed using 5.2cg of vector primer DNA (Phar- 
macia) and 3Opg of poly(A)+ RNA according to the method of 
Okayama and Berg [9]. 
2.5. Colony screening 
Correspondence address: K. Hayashi, Department of Pharmaceutics, Escherichia coli HBlOl was transformed with recombinant DNA 
Gifu Pharmaceutical University, Mitahora-Higashi S-6-1, Gifu 502, and colony hybridization was carried out as described previously 
Japan [lo]. The DNA fragment used as a probe was a 358 base-pair (bp) 
PubiMed by Etsevier Science ~btisbers B. V. (Biomedical Division) 
00145793/90/$3.50 0 1990 Federation of European Biochemical Societies 283 
Volume 261, number 2 FEBS LETTERS February 1990 
NcoI-PvuII fragment of pS2Bl cDNA obtained from MCF-7 cells 
[IO], which was nick-translated with [a-32P]dCTP (3000 CVmmol) to 
the specific activity of 2-3 x 10’ cpm/Fg according to the method of 
Weinstock et al. [ll]. DNA sequencing was performed by the method 
of Sanger et al. [12]. 
2.6. RNA blot hybridization analysis 
I 
Poly(A)* RNAs were prepared (described above) from human 
breast cancer cells (MCF-7) cultured in the presence of estrogen 
(10-s M) and from five gastric cancer cells. Poly(A)+ RNAs (15 pg) 
were denatured in the presence of 50% formamide containing 2.2 M 
formaldehyde, 20 mM morpholinopropane sulfonic acid CpH 7.0), 
5 mM sodium acetate and a nitrocellulose filter (Schleicher & Shuell), 
and then baked in a vacuum oven for 5 h at 75°C according to the 
standard method [13]. The filter was prehybridized, hybridized and 
then washed as described previously [IO]. 
Fig.2. Restriction map and sequencing procedure of pS2GC. The 
open box and the hatched box denote the regions encoding mature 
pS2 protein and the signal peptide, respectively. Straight lines on 
both sides of these boxes indicate the 5’ and 3’ untranslated 
nucleotide sequences. 5’ and 3 ’ wavy lines are the poly(dG)-poly(dC) 
tail and the ply-poly(dT) tract, respectively. The relevant 
restriction sites are shown together with nucleotide numbers derived 
from fig.3 in the parentheses. The length and direction of the 
3. RESULTS 
The pS2 protein was purified from serum-free condi- 
tioned medium of MKN-45 cells by following essential- 
ly the same procedure as from human breast cancer 
cells (MCF-7) [3]. This pS2 protein synthesis in 
MKN-45 celis was not induced by estrogen and the con- 
tent of pS2 in serum-free medium conditioned by this 
cell line was about l/100 of that by MCF-7 cells sup- 
plemented with estrogen (lo-* M) (data not shown). 
Fig. 1 shows the final step of purification of pS2 protein 
achieved by reverse-phase high-performance liquid 
chromatography with a pBondapak Cts column pS2 
was recovered at the same elution position as that from 
MCF-7 cell. Approximately 500 ng of pS2 protein was 
purified from 6 1 of the conditioned medium containing 
6 Fg of pS2 protein. The NHz-terminal amino acid se- 
quence of the pS2 protein obtained was as follows: Glu- 
~a-Gin-Thr-Glu-Thr-Cys-Thr-V~-~a-Pro-. This se- 
quence is completely identical to the NHz-terminal se- 
quence of pS2 protein purified from MCF-7 cells [3]. 
To determine the entire structure of pS2 protein pro- 
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Fig.]. Final step of p~i~cation of pS2 protein from serum-free 
medium conditioned by MKN-45 cells. The pS2-containing fractions 
were separated by reverse-phase high-performance liquid 
chromatography on a,uBondapak Cts column as described in section 
2. The column eluate was monitored at 210 nm (solid line), and the 
broken line shows the percentages of acetonitrile in the elution 
medium. pS2 obtained is indicated by the black bar. The arrow 
denotes the elution position of pS2 protein purified from MCF-7 cells 
under the same chromatographic onditions. 
c 
, 
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sequenced restriction fragments are illustrated by the arrows. 
duced in this cell line, cDNA clones were isolated from 
the MKN-45 cell cDNA library as described in section 
2. Seven were obtained from approximately 1 x lo5 
ampicillin-resistant colonies as hybridization-positive 
ones. Thus, about 0.007% of the total mRNA 
molecules prepared from the cells is thought to encode 
the pS2 protein. The content is about l/l00 of that in 
MCF-7 cells, which is reported to be about 0.8% [14]. 
Of these, three clones that seemed to contain a full- 
length cDNA were selected and analyzed for their 
nucleotide sequences as schematized in fig.2. All these 
clones contained an identical cDNA insert of 490 bp, 
excluding poly(dA)-poly(dT) tract and the poly(dG)- 
poly(dC) tail, hereafter referred to as pS2GC. 
As shown in fig.3, pS2GC has a single open reading 
frame of 252 nucleotides. The sequence of pS2GC is 
identical to that of pS2 cDNA previously isolated from 
MCF-7 cells 121 except for one nucleotide (indicated by 
* in fig.3). The nucleotide 289 (C) is reported to be G 
in the sequence of pS2 cDNA [2] but to be C in the se- 
quence of the pS2 gene [ 151. pS2GC is thought to repre- 
sent a full-length cDNA because its translational 
product was detected at the same migration position 
corresponding to about 600 nucleotides as pS2 mRNA 
from MCF-7 cells (fig.4). The sequence of the first 11 
amino acids from NHz-terminus of pS2 protein 
purified from the medium corresponds to that of the 
deduced protein extending from the amino acid 25, in- 
dicating that the preceding hydrophobic region con- 
sisting of 24 amino acids is a signal peptide (underlined 
in fig.3) and that the gene product of 84 amino acids is 
secreted as a mature protein of 60. These results clearly 
show that MKN-45 cells express the pS2 gene and pro- 
cess the gene product in the same manner as MCF-7 
cells. 
Levels of pS2 mRNA in five human gastric cancer 
cell lines were examined by RNA blot hybridization 
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-40 -30 -20 -10 
ATCCCTGACTCGGGGTCGCCTTTGGAGCAGAGAGGAGGCA 
1 10 20 30 40 50 60 
ATGGCCACCATGGAGAACAAGGTGATCTGCGCCCTGGTCCTGGTGTCCATGCTGGCCCTC 
MetAlaThrHetGluAsnLysValIleCysA~aLeuValLeuValSerHetLeuAlaLeu 
1 10 20 
70 80 90 100 110 120 
GGCACCCTGGCCGAGGCCCAGACAGAGACGTGTACAGTGGCCCCCCGTGAAAGACAGAAT 
GlyThrLeuAlaGluAlaG1nThrGluThrCysThrValAlaPr~ArgGluAr~GlnAsn 
30 40 
130 140 150 160 170 180 
TGTGGTTTTCCTGGTGTCACGCCCTCCCAGTGTGCAAATAAGGGCTGCTGTTTCGACGAC 
CysGlyPheProGlyValThrProSerGlnCysAlaAsnLysGlyCysCysPheAspAsp 
50 60 
190 200 210 220 230 240 
ACCGTTCGTGGGGTCCCCTGGTGCTTCTATCCTAATACCATCGACGTCCCTCCAGAAGAG 
ThrValArgGlyValProTrpCysPheTy~ProAsnThrIleAspV~lProProGluGlu 
70 SO 
250 260 270 280 290 300 
GAGTGTGAATTTTAGACACTTCTGCAGGGATCTGCCTGCATCCTGACGCGGTGCCGTCCC 
GluCysGluPhe l 
310 320 330 340 350 360 
CAGCACGGTGATTAGTCCCAGAGCTCGGCTGCCACCTCCACCGGACACCTCAGACACGCT 
370 380 390 400 410 420 
TCTGCAGCTGTGCCTCGGCTCACAACACAGATTGACTGCTCTGACTTTGACTACTCAAAA 
430 440 450 
TTGGCCTAAAAATTAAAAGAGATCGATATT 
Fig.3. Nucleotide sequence of pS2GC and the deduced amino acid 
sequence. Nucleotides are numbered in the 5’- to 3’-direction, 
beginning with the first adenine of the initiating methionine and 
ending with the last nucleotide just before the poly(dA) tract. 
Nucleotides in the 5 ’ untranslated region have negative numbers. The 
deduced amino acid sequence is shown below the nucleotide sequence 
with numbering starting from the initiating methionine. The region 
of the signal peptide is underlined. One nucleotide, 289, different 
from the sequence of pS2 cDNA previously isolated from MCF-7 
cells [lo] is indicated by *. 
analysis. As shown in fig.4A, a single band of RNA 
was detected at the same migration position as that 
from MCF-7 cells (lane 1) in two cell lines (MKN-45 
and KATO-III) derived from poorly differentiated 
adenocarcinoma (lanes 2 and 3, respectively). The 
amount of pS2 mRNA in MKN-45 cells was much less 
than that in MCF-7 cells cultured in the presence of 
A 
Origin - 
285 RNA - 
185 RNA - 
pS2GC mRNA ) 
Fig.4. Levels of pS2 mRNA and pS2 protein produced by five human gastric cancer cells. (A) RNA blot hybridization analysis for pS2 mRNA 
was carried out on poly(A)+ RNAs separated from MCF-7 cells cultured in the presence of estrogen (lo-” M) (1), MKN-45 (2), KATO-III (3), 
MKN-74 (4), MKN-28 (5), and MKN-1 cells (6) as described in section 2. Human rRNA was used as a molecular size marker. (B) The amount 
of pS2 protein secreted into the medium by five human gastric cancer cells was determined as described in section 2 and expressed as ng per day 
per 1 x lo6 cells. Numbers on the abscissa correspond to the lane numbers in (A). 
1 23456 
estrogen as described above. As shown in fig.rlB, the 
two cell lines synthesized and secreted pS2 protein into 
the conditioned medium with comparable levels. At 
present, discrepancies on the mRNA levels and pS2 
protein between MKN-45 and KATO-III cells are 
unclear. No bands were detected in another cl1 line 
(MKN-74) derived from well-differentiated adenocar- 
cinema (lane 4), although the cells did synthesize and 
secrete pS2 protein. This is probably due to the 
presence of a level of pS2 mRNA in the cells lower than 
that detectable in the assay because the amount of pS2 
protein secreted by the cells was l/10 of that by 
MKN-45 or KATO-III cells. Thus, the levels of pS2 
mRNA in five human gastric cancer cells correlate well 
with those of pS2 protein secreted by these cells. These 
results seem to indicate correlation between expression 
of pS2 gene and malignant level of gastric cancer cells. 
4. DISCUSSION 
The five human gastric cancer cell lines used in the 
present study were established from metastatic car- 
cinoma of patients with various types of gastric cancer 
[ 16,171. Microscopically, MKN- 1, MKN-28 and 
MKN-74 cells were classified in the category of well dif- 
ferentiated adenocarcinomas whereas MKN-45 and 
KATO-III cells were considered to be poorly differen- 
tiated ones. Production of pS2 protein by these cells ap- 
peared to depend on the state of differentiation of the 
cells in the case of cells originated from adenocar- 
cinemas because poorly differentiated cells synthesized 
and secreted this polypeptide but well differentiated 
ones did not and because the level of pS2 protein in the 
medium was reduced significantly by treatment of 
MKN-45 cells with retinoic acid, which is known to in- 
duce differentiation of some tumor cells [18-201. 
In human breast cancer cells (MCF-7), expression of 
B 
I 
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the pS2 gene is under strict control of estrogen at the 
transcriptional evel [4]. Recent extensive investigation 
in human tissue specimens indicates that expression of 
the pS2 gene could be classified into two categories 
depending on tissue type. One is estrogen-dependent, as
in MCF-7 cells; and the other is estrogen-independent. 
Of 180 breast cancer specimens, 129 (72%) are estrogen 
receptor-positive; and 87 (67%) of these are pS2 
mRNA and/or pS2 protein-negative, whereas only 2 
(40/o) of 51 estrogen receptor-negative specimens are 
pS2 mRNA and/or pS2 protein-positive [7]. From 
those findings, expression of the pS2 gene was conclud- 
ed to be limited to a subclass of human breast cancer 
cells containing estrogen receptor as represented by 
MCF-7 cells. 
As to the second category of expression of the pS2 
gene, normal stomach mucosa is believed to synthesize 
pS2 mRNA and secrete pS2 protein [7], both of which 
seem identical to those in MCF-7 cells [8]. The level of 
pS2 mRNA in the stomach was comparable to that in 
MCF-7 cells, but expression of the pS2 gene in the 
stomach cells was not under the control of estrogen 
because estrogen receptors were not detected in the 
stomach and because there was no significant dif- 
ference in the amount of pS2 mRNA and pS2 protein 
between males and females. 
MKN-45 cells do not respond to estrogen with regard 
to cell growth and induction of pS2 protein synthesis 
(data not shown). Thus, MKN-45 cells are thought to 
represent the stomach-type expression of the gene, 
which is not regulated by estrogen. As regards the 
unresponsiveness of pS2 gene to estrogen in MKN-45 
cells, further research is warranted. 
The results obtained showed that the pS2 gene is ex- 
pressed in gastric cancer cell lines as in MCF-7 cells and 
implicated the association with the malignant level of 
the cells. 
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